InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,469.30
(
0.39%
)
US TECH 100
19,175.20
(
0.00%
)
Dow Jones
39,112.16
(
-0.76%
)
Brent Oil
84.51
(
0.38%
)
Bitcoin
61,683.20
(
-0.21%
)
Post# of 252358
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

poorgradstudent

Send PM Follow Ignore
Followers 73
Posts 3426
Boards Moderated 1
Alias Born 04/28/2004

poorgradstudent

Re: mcbio post# 155844

Friday, 01/25/2013 2:02:49 PM

Friday, January 25, 2013 2:02:49 PM

Post# of 252358

I'm thinking in terms of more apples-to-apples small-cap biotech comparisons to THLD (i.e., sub-$500M market cap).



I guess I don't see why that matters. The inference I took from your post is whether or not we can interpret a level of confidence from the size of the milestone payment prior to phase III commencement.

I don't claim to know the answer to that, but I don't think it depends on the market cap of the company receiving the milestone.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up